Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TAKHZYRO Inj Lös 300 mg/2ml Durchstf
Drug
TAKHZYRO, Injektionslösung
Langzeitprophylaxe von Attacken des hereditären Angioödems
02.99.0. – various
HAM – Human medicine
LSPA – Parenteral solution
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
6/6/2019
12/31/9999
Dosage strength
TAKHZYRO 300mg/2mL, Injektionslösung
Langzeitprophylaxe von Attacken des hereditären Angioödems
02
Z – approved
Package
7680669120023
No information made available
A/R – Authorised / referenced
1 vial(s)
002
Z – approved
Declaration
Component
300 mg lanadelumabum
dinatrii phosphas dihydricus
acidum citricum monohydricum
histidinum
natrii chloridum
polysorbatum 80
aqua ad iniectabile
acidum citricum monohydricum
histidinum
natrii chloridum
polysorbatum 80
aqua ad iniectabile
Authorisation holder
7601001325050
Takeda Pharma AG
8152 Opfikon (ZH)
8152 Opfikon (ZH)
Date of revision of the text
10/1/2023
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.